Sort   by:  
 Page size 
UnknownEfficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19.
Not available
S-EPMC11416433 | biostudies-literature
UnknownERG Functionally Overlaps with Other Ets Proteins in Promoting TH9 Cell Expression of Il9 during Allergic Lung Inflammation.
Not available
S-EPMC10230589 | biostudies-literature
UnknownPharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.
Not available
S-EPMC10390421 | biostudies-literature
UnknownWithdrawing Ixekizumab in Patients With Psoriatic Arthritis Who Achieved Minimal Disease Activity: Results From a Randomized, Double-Blind Withdrawal Study.
Not available
S-EPMC8457232 | biostudies-literature
Sort   by:  
 Page size